2015 Antineoplastics

Drugs that target EGFR: CETUXIMAB/PANITUMUMAB, ERLOTINIB/GEFITINIB

Therapeutic Uses

CETUXIMAB/PANITUMUMAB

ERLOTINIB, GEFITINIB

having the "right" mutation (and we don't know what that is) means the difference between a "cure" and no response

Email: Dr. Janet Fitzakerley | ©2015 University of Minnesota Medical School Duluth | Last modified: 11-apr-15 9:39 AM